PRELUDE CAPITAL MANAGEMENT, LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q4 2019$857,000
+76.3%
7,360
+73.4%
0.03%
+50.0%
Q3 2019$486,000
+956.5%
4,244
+748.8%
0.02%
+450.0%
Q3 2017$46,0005000.00%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q3 2017.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders